查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1871054

生物降解医用塑胶市场：按产品类型、材料类型、加工技术、产品形式、应用和最终用户划分－2025年至2032年全球预测

Biodegradable Medical Plastics Market by Product Type, Material Type, Processing Technology, Product Forms, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，可生物降解医用塑胶市场将成长至 93.5 亿美元，复合年增长率为 7.90%。

关键市场统计数据
基准年 2024 50.9亿美元
预计年份：2025年 54.6亿美元
预测年份 2032 93.5亿美元
复合年增长率 (%) 7.90%

随着可生物降解医用塑胶在全球医疗保健系统中得到应用，临床表现与永续性正日益融合。

医疗保健产业正处于关键的转折点，环境保护与临床疗效必须兼顾。可生物降解的医用塑胶已成为解决一次性医疗废弃物日益增多、废弃物处理难题以及聚合物基医疗设备碳足迹等问题的可行方案。聚合物化学、积层製造和加工技术以及可灭菌配方的进步，使设计人员和製造商能够在不影响患者安全或符合监管规定的前提下，重新设计一次性产品和耐用零件。

材料多样化、混合製造和不断发展的监管采购框架如何共同重塑可生物降解医用塑胶的未来应用路径

一系列相互关联的变革正在再形成可生物降解医用塑胶的格局，这些变革正在重塑供应链、材料优先顺序和製造模式。首先，材料多样化正在推动能力的提升。聚乳酸和聚己内酯等替代材料不再是小众产品，而是凭藉改进的配方和添加剂组合，提高了耐灭菌性和机械强度，成为更广泛医疗应用领域的有力竞争者。同时，淀粉基复合材料和新型共聚物为需要快速生物降解的一次性耗材提供了经济高效的选择。

评估2025年美国关税调整如何推动医用聚合物供应链中的供应商多元化、近岸外包和垂直整合

美国近期推出的政策措施和2025年关税调整对医用聚合物及相关组件的国际供应链产生了显着影响。部分进口树脂和成品聚合物组件关税的提高迫使製造商重新评估筹资策略、库存管理政策和供应商多元化计画。这些贸易政策的变化促使企业更加关注近岸外包和扩大国内生产能力，以确保关键医疗产品的持续供应。

将产品类型、材料化学、加工技术、产品形式、应用类别和最终用户与市场接受度和技术要求联繫起来的综合細項分析

细緻的细分框架清楚地阐明了可生物降解医用塑胶能够立即发挥价值的领域以及仍存在技术挑战的领域。基于产品类型的机会集中在手套和口罩等耗材上，这些耗材的一次性设计符合生物降解途径；而包括检测套组和X光片在内的诊断设备则需要仔细评估其无菌性和材料透明度；牵开器和手术刀等外科器械对机械可靠性和耐灭菌性提出了更高的要求；透析设备和人工呼吸器等治疗设备则对性能和耐用性提出了复杂性能的要求。

区域管理体制、采购优先事项和製造地将如何影响美洲、欧洲、中东和非洲以及亚太地区的采用和商业化路径

受管理体制、供应链布局和医疗采购惯例等因素驱动的区域趋势，将对可生物降解医用塑胶的普及路径产生重大影响。在美洲，采购机构和大型医疗系统正日益将环境标准纳入竞标流程，而北美製造业也迅速回应了对具有韧性的近岸供应链网路的需求。这种环境有利于那些兼具检验的临床性能、透明的永续性和本土生产能力的供应商。

为什么成熟的聚合物製造商、灵活的契约製造、医疗设备原始设备製造商和学术研究人员的汇聚将决定可生物降解医用塑胶商业化的最终赢家？

生物降解医用塑胶领域的竞争格局呈现出多方面的特征：一方面，成熟的聚合物供应商正拓展医用级配方业务；另一方面，医疗设备製造商正积极融入永续设计理念；契约製造製造商正努力建构检验能力；此外，一些专注于创新生物降解化学技术的专业Start-Ups也在不断开拓创新。现有材料供应商利用其复合技术和全球分销网络，提供符合可萃取性和可浸出性要求的医用级产品。同时，医疗设备製造商（OEM）也越来越多地从初始设计阶段就纳入永续性标准，以确保产品与临床工作流程和灭菌製程的兼容性。

产业领导者可立即实施切实有效的高影响力策略，以加速检验、确保供应链的韧性，并在不影响临床表现的前提下整合生物降解性。

产业领导者应优先考虑切实可行的策略，将技术潜力转化为广泛的临床应用。首先，应在产品开发生命週期的早期阶段就整合材料鑑定，在进行机械和功能测试的同时，同步进行生物相容性、灭菌相容性和可萃取物/可浸出物测试。早期协调一致的检验能够减少监管申报过程中出现意外问题，并缩短从原型到临床评估的时间。

采用混合方法，结合关键相关人员访谈、实验室检验、生命週期评估和供应链图谱分析，确保获得可靠且可操作的洞见。

本执行摘要的研究整合了初步访谈、实验室检验研究和二手文献，旨在对可生物降解医用塑胶进行严谨、多角度的分析。初步研究包括对材料科学家、医疗设备工程师、采购经理和灭菌专家进行结构化访谈，以了解实际操作和实施障碍。实验室检验包括机械性能测试、灭菌週期评估以及可萃取物/可浸出物筛检，以评估材料在典型应用中的适用性。

技术准备、供应链韧性和协作检验途径的平衡整合将决定可生物降解医用塑胶从试点阶段走向标准临床实践的路径。

生物降解医用塑胶在技术上可行，在策略上也具有重要意义，它既能减少医疗保健产业对环境的影响，又能保障病人安全和医疗设备的功能。向生物降解替代品的过渡在不同产品类型中进展速度各异：大消费量耗材和包装材料可能率先采用，而植入和高性能手术器械则需要更广泛的检验和更长的整合週期。这项进展取决于材料供应商、製造商、临床医生和监管机构能否携手合作，就安全性、灭菌和生命週期结果达成共识。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 基于聚乳酸（PLA）的外科植入和缝线的监管核准趋势正在加速发展。
  • 复合添加剂的创新可提高医用聚合物的生物降解速率和机械强度
  • 3D列印生物可降解支架在组织工程和再生医学的应用日益广泛
  • 开发含有奈米材料的抗菌生物分解性塑胶，以降低感染风险
  • 利用可生物降解的生物聚酯，拓展一次性医疗设备的环保包装解决方案
  • 生质塑胶生产商与医疗保健机构建立策略伙伴关係，拓展永续供应链
  • 基于PHA的药物递送系统的临床评估表明，患者疗效有所改善。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依产品类型分類的可生物降解医用塑胶市场

  • 消耗品
    • 手套
    • 面具
  • 诊断设备
    • 检测套组
    • X光片
  • 手术器械
    • 牵开器
    • 女性
  • 治疗设备
    • 透析设备
    • 人工呼吸器

9. 依材料类型分類的可生物降解医用塑胶市场

  • Polybutylene Adipate Terephthalate
  • 聚己内酯
  • 聚乳酸
  • 淀粉基复合树脂

第十章：按加工技术分類的可生物降解医用塑胶市场

  • 3D列印
  • 吹塑成型
  • 挤压
  • 射出成型

第十一章：按产品类型分類的可生物降解医用塑胶市场

  • 板条箱和货柜
  • 模製零件
  • 片材和薄膜

第十二章：按应用分類的可生物降解医用塑胶市场

  • 药物输送系统
    • 微球载体
    • 奈米颗粒载体
  • 医院设施
    • 手术器械
    • 托盘和盆
  • 植入
    • 永久植入
    • 暂时植入
  • 包装
    • 泡壳包装
    • 注射器包装

第十三章 依最终用户分類的可生物降解医用塑胶市场

  • 诊断中心
    • 血液检测中心
    • 诊断影像中心
  • 医疗设施
    • 诊所
    • 医院
  • 製药公司
  • 大学和研究机构

第十四章 各地区可生物降解医用塑胶市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 生物降解医用塑胶市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章：各国可生物分解医用塑胶市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Advanced & Functional Technologies For Biocomposites SL
    • Amcor PLC
    • Arkema Group
    • Ashland Inc.
    • Avient Corporation
    • BASF SE
    • Biome Technologies plc
    • Cardia Bioplastic by SECOS Group Limited
    • Celanese Corporation
    • Corbion NV
    • Danimer Scientific, Inc.
    • Eastman Chemical Company
    • Evonik Industries AG
    • Green Dot Bioplastics Inc
    • Koninklijke DSM NV
    • NatureWorks LLC by Cargill Incorporated
    • Neste Oyj
    • Novamont SpA by Versalis
    • Sabic
    • Solvay SA
    • Teijin Limited
    • TEYSHA TECHNOLOGIES LIMITED
    • Toray Industries, Inc.
    • Trinseo PLC
Product Code: MRR-1A1A064C05E6

The Biodegradable Medical Plastics Market is projected to grow by USD 9.35 billion at a CAGR of 7.90% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 5.09 billion
Estimated Year [2025] USD 5.46 billion
Forecast Year [2032] USD 9.35 billion
CAGR (%) 7.90%

Framing the convergence of clinical performance and sustainability as biodegradable medical plastics move from innovation labs into healthcare systems worldwide

The medical sector stands at a pivotal juncture where environmental stewardship and clinical performance must coexist. Biodegradable medical plastics have emerged as a pragmatic response to escalating concerns about single-use waste, end-of-life disposal challenges, and the carbon footprint associated with polymer-based medical devices. Advances in polymer chemistry, additive and subtractive manufacturing, and sterilization-compatible formulations now allow designers and manufacturers to reimagine disposables and durable components without compromising patient safety or regulatory compliance.

Transitioning from legacy petrochemical-derived materials to biodegradable alternatives demands a deep appreciation of material science, device functionality, and the clinical use environment. Clinicians and procurement teams increasingly require evidence that biodegradable solutions meet established biocompatibility, sterilization resilience, and mechanical performance standards. At the same time, environmental managers and sustainability officers prioritize materials that facilitate composting, enzymatic degradation, or safe incineration with lower toxic emissions. This intersection of clinical requirements and sustainability imperatives defines the current strategic challenge for manufacturers, suppliers, and health systems.

Consequently, stakeholders must assess new candidate materials alongside manufacturing processes such as extrusion and injection molding, as well as emerging techniques like 3D printing that enable part consolidation and function-specific architectures. Adoption pathways are shaped by clinical validation, regulatory acceptance, supply chain reliability, and lifecycle management practices. The remainder of this executive summary synthesizes these dynamics, highlights transformative shifts, and provides actionable guidance for advancing biodegradable medical plastics from promising innovation to institutionalized standard practice.

How material diversification, hybrid manufacturing, and evolving regulatory procurement frameworks are jointly reshaping the future adoption trajectory of biodegradable medical plastics

The landscape for biodegradable medical plastics is being reshaped by a series of interlocking transformative shifts that reconfigure supply chains, material priorities, and manufacturing paradigms. First, materials diversification drives capability; alternatives such as polylactic acid and polycaprolactone are no longer niche curiosities but viable candidates for a wider array of medical applications due to improved formulations and additive packages that enhance sterilization tolerance and mechanical strength. Alongside these, starch blends and novel copolymers offer cost-effective pathways for single-use consumables where rapid biodegradation is acceptable.

Second, processing technology is evolving from traditional high-volume molding toward a hybrid model that leverages both injection molding for standardized parts and 3D printing for patient-specific and low-volume devices. As 3D printing matures, it enables geometries and internal architectures that reduce raw material use, improve device function, and allow for rapid design iteration-factors that accelerate clinical validation cycles and reduce time-to-clinic for novel biodegradable devices. Concurrently, advances in blow molding and extrusion expand the range of form factors available for packaging and film applications, enabling biodegradable formulations to enter sterile barrier applications and flexible packaging systems.

Third, regulatory and procurement ecosystems are adapting. Regulatory authorities have increased scrutiny of material biocompatibility, extractables and leachables, and sterilization validation for biodegradable polymers, prompting manufacturers to invest in comprehensive preclinical and compatibility testing earlier in development. Procurement teams within hospitals and pharmaceutical companies are beginning to weigh the total lifecycle implications of product choices, leading to pilot programs that integrate waste-disposal costs and environmental criteria into purchasing decisions. Collectively, these shifts favor suppliers that offer validated performance, traceable supply chains, and transparent environmental credentials, thereby accelerating the integration of biodegradable plastics in clinical practice.

Assessing how the 2025 United States tariff adjustments are prompting supplier diversification, nearshoring, and vertical integration within medical polymer supply chains

Recent policy measures and tariff adjustments introduced by the United States in 2025 have exerted a discernible influence across international supply chains for medical polymers and ancillary components. Increased duties on certain imported resins and finished polymeric components have compelled manufacturers to reassess sourcing strategies, inventory policies, and supplier diversification plans. These trade policy changes have amplified attention on nearshoring and domestic capacity expansion as firms seek to protect continuity of supply for critical medical products.

Manufacturers responding to tariff-induced cost pressures are prioritizing supplier consolidation with partners who demonstrate consistent quality, traceable raw material provenance, and the ability to scale. For some, this has meant negotiating longer-term procurement agreements to stabilize input costs and secure capacity allocations. Others have accelerated qualification of alternative biodegradable resins produced outside the affected tariff categories, while maintaining rigorous biocompatibility and sterilization validation to preserve clinical acceptability.

The cumulative tariff environment has also catalyzed investment in vertical integration for a subset of producers that view control over polymer compounding and formulation as a strategic buffer against external price fluctuations. In parallel, contract manufacturers and toll processors with domestic capabilities have seen elevated interest from original equipment manufacturers seeking to mitigate cross-border risks. Healthcare systems and procurement offices are reacting by revisiting supply contracts and piloting vendor diversification to ensure resilience.

It is important to note that the tariff-driven reconfiguration is not uniform across product types and geographies. Components that require specialized compounding or tight regulatory pedigree-such as implantable device components-remain sensitive to supplier continuity, while higher-volume consumables can more readily be requalified across multiple vendors. The net effect is a supply chain that is more regionally focused, where trade policy imperatives influence decisions about where to locate production, which suppliers to partner with, and how to structure inventory strategies to preserve clinical continuity and cost-effectiveness.

Comprehensive segmentation analysis linking product types, material chemistries, processing technologies, product forms, application categories, and end users to adoption potential and technical requirements

A nuanced segmentation framework clarifies where biodegradable medical plastics can deliver immediate value and where technical hurdles remain. Based on product type, opportunities concentrate in consumables such as gloves and masks where single-use anatomy aligns with biodegradation pathways, while diagnostic devices that include testing kits and X-ray sheets demand careful evaluation of sterility and material transparency. Surgical devices such as retractors and scalpels present a higher bar for mechanical reliability and sterilization withstand, and therapeutic equipment including dialysis machines and respirators raise complex performance and longevity considerations.

Material type distinctions shape design choices and downstream processing. Polylactic acid offers a balanced profile for molded parts and sheets, polycaprolactone excels where flexibility and controlled degradation are required, polybutylene adipate terephthalate provides toughness in thicker structures, and starch blends present cost-efficient options for non-critical packaging and disposable items. Processing technology further differentiates application suitability. 3D printing allows for patient-specific geometries and rapid prototyping, blow molding yields hollow packaging and containers, extrusion facilitates continuous sheets and films, and injection molding remains the workhorse for consistent, high-volume components.

Product forms influence end-use integration and sterilization strategy. Crates and containers demand robust, reusable designs with sterilization compatibility, molded parts must balance surface finish and tolerances for instrument housings, and sheets and films focus on barrier properties and sealability for sterile packaging. Application-driven segmentation highlights distinct regulatory and performance pathways. Drug delivery systems involving microsphere carriers and nanoparticulate carriers require rigorous biocompatibility and release profiling, hospital equipment spanning surgical instruments and trays and basins must endure repeated sterilization cycles, implants categorized as permanent or temporary impose divergent degradation and tissue interaction requirements, and packaging formats such as blister packs and syringe packaging prioritize barrier integrity and compatibility with aseptic filling.

Finally, end-user segmentation informs adoption velocity and purchase criteria. Diagnostic centers including blood testing centers and imaging centers emphasize diagnostic accuracy and device specificity, healthcare facilities ranging from clinics to hospitals prioritize cost, disposability, and waste-management implications, pharmaceutical companies require validated materials for primary packaging and combination products, and universities and research institutions drive early-stage validation and translational research that informs commercial uptake. Aligning material choice, processing technology, and product form to these end-user expectations is central to designing viable biodegradable medical plastic solutions that can move from pilot to standard practice.

How regional regulatory regimes, procurement priorities, and manufacturing footprints across the Americas, Europe Middle East & Africa, and Asia-Pacific shape adoption and commercialization pathways

Regional dynamics exert strong influence on adoption pathways for biodegradable medical plastics, driven by regulatory regimes, supply chain footprints, and healthcare procurement practices. In the Americas, procurement agencies and major health systems increasingly integrate environmental criteria into tender processes, and North American manufacturing capacity has been responsive to demands for resilient, nearshore supply chains. This environment favors suppliers that can combine validated clinical performance with transparent sustainability credentials and domestic production capabilities.

In Europe, Middle East & Africa, regulatory frameworks and national sustainability commitments create both incentives and procedural hurdles. European regulatory authorities maintain stringent material safety and lifecycle reporting expectations, prompting manufacturers to invest in comprehensive compliance dossiers and third-party verification. In parts of the Middle East and Africa, rapid infrastructure development and rising healthcare demand create opportunities to introduce biodegradable options in new facilities, although adoption timing depends on logistical and regulatory alignment.

The Asia-Pacific region displays a broad spectrum of trajectories, with several markets advancing manufacturing capabilities, material innovation, and clinical adoption simultaneously. Regional manufacturing hubs supply polymers and finished components to global supply chains, while localized innovation ecosystems and academic partnerships accelerate trialing of biodegradable formulations and processing methods. Across all regions, cross-border trade dynamics, intellectual property considerations, and harmonization of safety standards remain central to how rapidly biodegradable medical plastics transition from pilot projects to routine procurement choices.

Why a blend of established polymer producers, agile contract manufacturers, device OEMs, and academic innovators will determine who wins in biodegradable medical plastics commercialization

Competitive dynamics in the biodegradable medical plastics space reflect a mixture of established polymer suppliers expanding into medical-grade formulations, device manufacturers integrating sustainable design principles, contract manufacturers building validation capabilities, and specialized startups pioneering novel biodegradable chemistries. Established materials suppliers are leveraging their compounding expertise and global distribution networks to offer medical-grade variants that meet extractables and leachables expectations, while device OEMs are increasingly embedding sustainability criteria into early-stage design decisions to ensure compatibility with clinical workflows and sterilization regimes.

Contract manufacturing organizations and precision molding houses that can demonstrate validated processes, cleanroom capabilities, and sterilization partnerships hold a strategic advantage because they reduce barriers for device makers to trial biodegradable alternatives without major retooling. Simultaneously, smaller innovators and university spin-outs contribute disruptive potential by introducing unique polymer blends and functional additives that target specific clinical challenges such as controlled degradation profiles or enhanced tissue integration for temporary implants.

Partnerships and consortiums that link material suppliers, device manufacturers, testing laboratories, and clinical partners are becoming a practical route to de-risk new product introductions. These collaborations accelerate materials qualification, share preclinical evidence, and create pathways for multi-center evaluations that satisfy both regulatory and procurement stakeholders. The competitive landscape rewards entities that combine technical rigor with an ability to scale supply reliably while maintaining necessary documentation for regulatory submissions and hospital procurement approvals.

Practical, high-impact strategies that industry leaders can implement immediately to accelerate validation, secure resilient supply chains, and integrate biodegradability without compromising clinical performance

Industry leaders should prioritize a set of actionable strategies to convert technical promise into widespread clinical adoption. First, integrate material qualification early in the product development lifecycle, ensuring that biocompatibility, sterilization compatibility, and extractables and leachables studies run in parallel with mechanical and functional testing. Early and coordinated validation reduces downstream surprises during regulatory submission and shortens the time between prototype and clinical evaluation.

Second, diversify supply chains while investing in strategic supplier relationships that offer traceable raw material provenance and consistency in polymer compounding. Where tariffs or trade uncertainty are material considerations, evaluate nearshoring options and partnerships with toll processors to secure production continuity. Third, adopt hybrid manufacturing strategies that leverage injection molding for high-volume repeatable parts and 3D printing for patient-specific or complex geometries, thereby optimizing cost, performance, and customization potential.

Fourth, engage proactively with regulatory authorities and procurement stakeholders to align on acceptable validation pathways and environmental reporting requirements. Pilot programs with health systems and diagnostic centers can provide real-world performance data that shortens procurement approval cycles. Fifth, implement lifecycle and end-of-life planning early, including compatibility with existing sterilization and waste-management infrastructure, and communicate environmental benefits with evidence-based lifecycle assessments. Finally, cultivate cross-sector collaborations that bring together material scientists, clinicians, sterilization experts, and supply chain specialists to address the multidisciplinary challenges inherent in biodegradable medical plastics.

An integrated mixed-methods approach combining primary stakeholder interviews, laboratory validation, lifecycle assessments, and supply chain mapping to ensure robust and actionable insights

The research underpinning this executive summary synthesized primary interviews, laboratory validation studies, and secondary literature to create a rigorous, multidimensional view of biodegradable medical plastics. Primary research included structured interviews with materials scientists, device engineers, procurement leaders, and sterilization experts to capture operational realities and adoption barriers. Laboratory validation incorporated mechanical testing, sterilization cycle assessments, and extractables and leachables screening to evaluate material suitability across representative application classes.

Secondary sources comprised peer-reviewed publications, regulatory guidance documents, standards from recognized bodies, and publicly available technical dossiers that describe material behavior and clinical use cases. Supply chain mapping and trade-flow analysis informed the assessment of tariff impacts and regional manufacturing capabilities, while lifecycle assessment methodologies were applied to compare end-of-life trajectories and environmental implications of candidate polymers. Where applicable, case studies of pilot programs and early commercial deployments provided context about clinical acceptance and procurement decision criteria.

Triangulation of these data streams ensured that conclusions are grounded in both laboratory-based evidence and real-world operational insights. Quality control measures included cross-validation of interview themes against laboratory findings and regulatory expectations, and methodological transparency was maintained through clear documentation of data sources, sample sizes, and testing protocols. This mixed-methods approach supports robust, actionable recommendations tailored to diverse stakeholders across the value chain.

A balanced synthesis of technical readiness, supply chain resilience, and collaborative validation pathways that determines how biodegradable medical plastics move from pilots to standard clinical practice

Biodegradable medical plastics represent a technically viable and strategically important pathway for reducing the environmental footprint of healthcare while maintaining patient safety and device functionality. The transition to biodegradable alternatives will be uneven across product categories: high-volume consumables and packaging are poised for earlier adoption, while implants and high-performance surgical instruments require more extensive validation and longer integration timelines. Progress will hinge on coordinated efforts among material suppliers, manufacturers, clinicians, and regulators to align on safety, sterilization, and lifecycle outcomes.

Supply chain resilience, influenced by regional manufacturing capabilities and trade policies, will continue to shape where and how biodegradable solutions are produced and sourced. Equally important is the capacity of the industry to generate convincing clinical and environmental evidence that satisfies procurement teams and regulatory authorities. Those organizations that invest in early validation, flexible manufacturing strategies, and transparent lifecycle reporting will be best positioned to capture the operational and reputational benefits of sustainable materials.

Ultimately, the promise of biodegradable medical plastics depends less on a single breakthrough material and more on the integration of validated formulations, scalable processing methods, and aligned stakeholder incentives. By focusing on pragmatic pilots, rigorous testing, and strategic partnerships, the sector can convert innovation into measurable reductions in clinical plastic waste while safeguarding clinical outcomes and supply chain continuity.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Regulatory approval trends for PLA-based surgical implants and sutures gaining momentum
  • 5.2. Innovations in compound additives to enhance biodegradation rates and mechanical strength of medical polymers
  • 5.3. Rising adoption of 3D printed biodegradable scaffolds for tissue engineering and regenerative medicine
  • 5.4. Development of antimicrobial biodegradable plastics infused with nanomaterials to reduce infection risks
  • 5.5. Expansion of eco-friendly packaging solutions for single-use medical devices using compostable biopolyesters
  • 5.6. Strategic partnerships between bioplastic producers and healthcare providers to scale sustainable supply chains
  • 5.7. Clinical evaluations of PHA-based drug delivery systems demonstrating improved patient outcomes

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biodegradable Medical Plastics Market, by Product Type

  • 8.1. Consumables
    • 8.1.1. Gloves
    • 8.1.2. Masks
  • 8.2. Diagnostic Devices
    • 8.2.1. Testing Kits
    • 8.2.2. X-ray Sheets
  • 8.3. Surgical Devices
    • 8.3.1. Retractors
    • 8.3.2. Scalpels
  • 8.4. Therapeutic Equipment
    • 8.4.1. Dialysis Machines
    • 8.4.2. Respirators

9. Biodegradable Medical Plastics Market, by Material Type

  • 9.1. Polybutylene Adipate Terephthalate
  • 9.2. Polycaprolactone
  • 9.3. Polylactic Acid
  • 9.4. Starch Blends

10. Biodegradable Medical Plastics Market, by Processing Technology

  • 10.1. 3D Printing
  • 10.2. Blow Molding
  • 10.3. Extrusion
  • 10.4. Injection Molding

11. Biodegradable Medical Plastics Market, by Product Forms

  • 11.1. Crates & Containers
  • 11.2. Molded Parts
  • 11.3. Sheets & Films

12. Biodegradable Medical Plastics Market, by Application

  • 12.1. Drug Delivery Systems
    • 12.1.1. Microsphere Carriers
    • 12.1.2. Nanoparticulate Carriers
  • 12.2. Hospital Equipment
    • 12.2.1. Surgical Instruments
    • 12.2.2. Trays and Basins
  • 12.3. Implants
    • 12.3.1. Permanent Implants
    • 12.3.2. Temporary Implants
  • 12.4. Packaging
    • 12.4.1. Blister Packs
    • 12.4.2. Syringe Packaging

13. Biodegradable Medical Plastics Market, by End User

  • 13.1. Diagnostic Centers
    • 13.1.1. Blood Testing Centers
    • 13.1.2. Imaging Centers
  • 13.2. Healthcare Facilities
    • 13.2.1. Clinics
    • 13.2.2. Hospitals
  • 13.3. Pharmaceutical Companies
  • 13.4. Universities and Research Institutions

14. Biodegradable Medical Plastics Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Biodegradable Medical Plastics Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Biodegradable Medical Plastics Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Advanced & Functional Technologies For Biocomposites SL
    • 17.3.2. Amcor PLC
    • 17.3.3. Arkema Group
    • 17.3.4. Ashland Inc.
    • 17.3.5. Avient Corporation
    • 17.3.6. BASF SE
    • 17.3.7. Biome Technologies plc
    • 17.3.8. Cardia Bioplastic by SECOS Group Limited
    • 17.3.9. Celanese Corporation
    • 17.3.10. Corbion NV
    • 17.3.11. Danimer Scientific, Inc.
    • 17.3.12. Eastman Chemical Company
    • 17.3.13. Evonik Industries AG
    • 17.3.14. Green Dot Bioplastics Inc
    • 17.3.15. Koninklijke DSM N.V.
    • 17.3.16. NatureWorks LLC by Cargill Incorporated
    • 17.3.17. Neste Oyj
    • 17.3.18. Novamont S.p.A. by Versalis
    • 17.3.19. Sabic
    • 17.3.20. Solvay S.A.
    • 17.3.21. Teijin Limited
    • 17.3.22. TEYSHA TECHNOLOGIES LIMITED
    • 17.3.23. Toray Industries, Inc.
    • 17.3.24. Trinseo PLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PRODUCT FORMS, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PRODUCT FORMS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. BIODEGRADABLE MEDICAL PLASTICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. BIODEGRADABLE MEDICAL PLASTICS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BIODEGRADABLE MEDICAL PLASTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY GLOVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY GLOVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY GLOVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY GLOVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY GLOVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY GLOVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MASKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MASKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MASKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MASKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MASKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MASKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TESTING KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TESTING KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TESTING KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TESTING KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TESTING KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TESTING KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY X-RAY SHEETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY X-RAY SHEETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY X-RAY SHEETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY X-RAY SHEETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY X-RAY SHEETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY X-RAY SHEETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SURGICAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SURGICAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SURGICAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SURGICAL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SURGICAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SURGICAL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY RETRACTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY RETRACTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY RETRACTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY RETRACTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY RETRACTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY RETRACTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SCALPELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SCALPELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SCALPELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SCALPELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SCALPELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SCALPELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY THERAPEUTIC EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY THERAPEUTIC EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY THERAPEUTIC EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY THERAPEUTIC EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY THERAPEUTIC EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY THERAPEUTIC EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY THERAPEUTIC EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY THERAPEUTIC EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIALYSIS MACHINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIALYSIS MACHINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIALYSIS MACHINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIALYSIS MACHINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIALYSIS MACHINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIALYSIS MACHINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY RESPIRATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY RESPIRATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY RESPIRATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY RESPIRATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY RESPIRATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY RESPIRATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYBUTYLENE ADIPATE TEREPHTHALATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYBUTYLENE ADIPATE TEREPHTHALATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYBUTYLENE ADIPATE TEREPHTHALATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYBUTYLENE ADIPATE TEREPHTHALATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYBUTYLENE ADIPATE TEREPHTHALATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYBUTYLENE ADIPATE TEREPHTHALATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYCAPROLACTONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYCAPROLACTONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYCAPROLACTONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYCAPROLACTONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYCAPROLACTONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYCAPROLACTONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYLACTIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYLACTIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYLACTIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYLACTIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYLACTIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYLACTIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY STARCH BLENDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY STARCH BLENDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY STARCH BLENDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY STARCH BLENDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY STARCH BLENDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY STARCH BLENDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY 3D PRINTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY 3D PRINTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY 3D PRINTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY 3D PRINTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY 3D PRINTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY 3D PRINTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY EXTRUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY EXTRUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY EXTRUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY EXTRUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY EXTRUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY EXTRUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PRODUCT FORMS, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PRODUCT FORMS, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CRATES & CONTAINERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CRATES & CONTAINERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CRATES & CONTAINERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CRATES & CONTAINERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CRATES & CONTAINERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CRATES & CONTAINERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MOLDED PARTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MOLDED PARTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MOLDED PARTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MOLDED PARTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MOLDED PARTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MOLDED PARTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SHEETS & FILMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SHEETS & FILMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SHEETS & FILMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SHEETS & FILMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SHEETS & FILMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SHEETS & FILMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MICROSPHERE CARRIERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MICROSPHERE CARRIERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MICROSPHERE CARRIERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MICROSPHERE CARRIERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MICROSPHERE CARRIERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MICROSPHERE CARRIERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY NANOPARTICULATE CARRIERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY NANOPARTICULATE CARRIERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY NANOPARTICULATE CARRIERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY NANOPARTICULATE CARRIERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY NANOPARTICULATE CARRIERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY NANOPARTICULATE CARRIERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HOSPITAL EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HOSPITAL EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HOSPITAL EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HOSPITAL EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HOSPITAL EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HOSPITAL EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HOSPITAL EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HOSPITAL EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TRAYS AND BASINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TRAYS AND BASINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TRAYS AND BASINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TRAYS AND BASINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TRAYS AND BASINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TRAYS AND BASINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PERMANENT IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PERMANENT IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PERMANENT IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PERMANENT IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PERMANENT IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PERMANENT IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TEMPORARY IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TEMPORARY IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TEMPORARY IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TEMPORARY IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TEMPORARY IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TEMPORARY IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PACKAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PACKAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PACKAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PACKAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PACKAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLISTER PACKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLISTER PACKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLISTER PACKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLISTER PACKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLISTER PACKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLISTER PACKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SYRINGE PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SYRINGE PACKAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SYRINGE PACKAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SYRINGE PACKAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SYRINGE PACKAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SYRINGE PACKAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLOOD TESTING CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLOOD TESTING CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLOOD TESTING CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLOOD TESTING CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLOOD TESTING CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLOOD TESTING CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY IMAGING CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY IMAGING CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY IMAGING CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY IMAGING CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY IMAGING CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HEALTHCARE FACILITIES, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HEALTHCARE FACILITIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HEALTHCARE FACILITIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HEALTHCARE FACILITIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HEALTHCARE FACILITIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HEALTHCARE FACILITIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HEALTHCARE FACILITIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL BIODEGRADABLE MEDICAL